Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 23% ± 9% | |
| astrocyte | 5 studies | 22% ± 5% | |
| microglial cell | 4 studies | 21% ± 4% | |
| epithelial cell | 4 studies | 23% ± 5% | |
| GABAergic neuron | 4 studies | 28% ± 8% | |
| glutamatergic neuron | 4 studies | 34% ± 12% | |
| macrophage | 4 studies | 21% ± 2% | |
| oligodendrocyte | 4 studies | 20% ± 3% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 5% | |
| dendritic cell | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1876.26 | 1445 / 1445 | 100% | 16.99 | 183 / 183 |
| ovary | 100% | 2834.89 | 180 / 180 | 100% | 21.69 | 430 / 430 |
| lung | 100% | 2163.23 | 578 / 578 | 100% | 15.38 | 1151 / 1155 |
| stomach | 100% | 1653.89 | 359 / 359 | 100% | 13.60 | 285 / 286 |
| intestine | 100% | 2291.87 | 966 / 966 | 100% | 12.48 | 525 / 527 |
| breast | 100% | 2416.91 | 459 / 459 | 99% | 20.91 | 1110 / 1118 |
| skin | 100% | 2348.90 | 1809 / 1809 | 99% | 18.35 | 467 / 472 |
| bladder | 100% | 2288.81 | 21 / 21 | 98% | 12.89 | 496 / 504 |
| brain | 98% | 1190.67 | 2592 / 2642 | 100% | 15.92 | 704 / 705 |
| pancreas | 100% | 1383.01 | 327 / 328 | 98% | 10.66 | 174 / 178 |
| thymus | 100% | 2694.99 | 653 / 653 | 97% | 11.58 | 589 / 605 |
| uterus | 100% | 2776.14 | 170 / 170 | 97% | 13.33 | 444 / 459 |
| prostate | 100% | 2164.19 | 245 / 245 | 96% | 10.73 | 483 / 502 |
| kidney | 100% | 1563.48 | 89 / 89 | 95% | 11.49 | 857 / 901 |
| liver | 100% | 980.93 | 226 / 226 | 91% | 9.25 | 368 / 406 |
| adrenal gland | 100% | 1869.88 | 258 / 258 | 85% | 6.19 | 195 / 230 |
| adipose | 100% | 2172.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1859.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1575.05 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3039.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.15 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 12.75 | 79 / 80 |
| peripheral blood | 98% | 1870.30 | 906 / 929 | 0% | 0 | 0 / 0 |
| heart | 96% | 941.98 | 830 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 11.27 | 43 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 12.28 | 27 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045869 | Biological process | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO_0032259 | Biological process | methylation |
| GO_0010629 | Biological process | negative regulation of gene expression |
| GO_0090309 | Biological process | positive regulation of DNA methylation-dependent heterochromatin formation |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0070828 | Biological process | heterochromatin organization |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005694 | Cellular component | chromosome |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_1990841 | Molecular function | promoter-specific chromatin binding |
| GO_0140949 | Molecular function | histone H3K9 trimethyltransferase activity |
| GO_0003682 | Molecular function | chromatin binding |
| GO_0046974 | Molecular function | histone H3K9 methyltransferase activity |
| GO_0140947 | Molecular function | histone H3K9me2 methyltransferase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0140948 | Molecular function | histone H3K9 monomethyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SETDB1 |
| Protein name | SET domain bifurcated histone lysine methyltransferase 1 Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (ERG-associated protein with SET domain) (ESET) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1) SET domain bifurcated histone lysine methyltransferase 1 (SET domain, bifurcated 1, isoform CRA_c) |
| Synonyms | KIAA0067 KMT1E hCG_39375 ESET |
| Description | FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. H3 'Lys-9' trimethylation is coordinated with DNA methylation . Required for HUSH-mediated heterochromatin formation and gene silencing. Forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation . Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1 . SETDB1 is targeted to histone H3 by TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells . Required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) . In ESCs, in collaboration with TRIM28, is also required for H3K9me3 and silencing of endogenous and introduced retroviruses in a DNA-methylation independent-pathway (By similarity). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing . The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions . . |
| Accessions | E9PAP1 ENST00000525956.5 E9PQM8 A0A8I5KT93 ENST00000423081.1 ENST00000368962.6 [Q15047-2] ENST00000692314.1 X6RHV1 ENST00000534805.5 Q15047 ENST00000368963.5 B0QZE6 X6R732 ENST00000498193.5 ENST00000692827.1 E9PS59 ENST00000271640.9 [Q15047-1] ENST00000448029.5 ENST00000368969.8 [Q15047-3] E9PRF4 ENST00000368964.3 |